Capitolis Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-311
Closed -$11K 142
2022
Q1
$11K Sell
311
-16,690
-98% -$571K ﹤0.01% 143
2021
Q4
$518K Hold
17,001
﹤0.01% 503
2021
Q3
$592K Sell
17,001
-5,396
-24% -$173K 0.01% 350
2021
Q2
$678K Buy
+22,397
New +$737K 0.01% 322

Other funds holding OGN

Capitolis Advisors's OGN Position: Q2 2022 in Review

Capitolis Advisors sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 311 shares — an estimated $11K sold.

Capitolis Advisors first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $678K in Q2 2021. 852 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Capitolis Advisors reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Capitolis Advisors sold 311 Organon & Co shares in Q2 2022, an estimated $11K.
  • Capitolis Advisors first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Capitolis Advisors's Organon & Co position peaked at $678K in Q2 2021.
  • 852 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Capitolis Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.